C12N 2830/38
Being a stuffer
Official title: being a stuffer
C12N2830/38 (Being a stuffer) appears on 72 US grants and 99 published applications in this corpus.
Search patents in C12N- Granted patents
- 72
- Published applications
- 99
- Assignees
- 66
- Inventors
- 240
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 6 | 11 |
| 2003 | 6 | 13 |
| 2004 | 3 | 16 |
| 2005 | 2 | 6 |
| 2006 | 5 | 4 |
| 2007 | 5 | 3 |
| 2008 | 1 | 0 |
| 2009 | 1 | 0 |
| 2010 | 3 | 3 |
| 2011 | 3 | 2 |
| 2012 | 2 | 2 |
| 2013 | 2 | 1 |
| 2014 | 3 | 2 |
| 2015 | 1 | 4 |
| 2016 | 2 | 0 |
| 2017 | 1 | 3 |
| 2018 | 3 | 2 |
| 2019 | 1 | 2 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 4 |
| 2023 | 0 | 7 |
| 2024 | 2 | 7 |
| 2025 | 2 | 3 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleic acid molecules containing spacers and methods of use thereof14 Apr 2026US 12,600,986 B2Astellas Gene Therapies, Inc.
- Nucleic acid molecules containing spacers and methods of use thereof28 Oct 2025US 12,453,783 B2St. Jude Children?S Research Hospital
- Variant RNAi against alpha-synuclein22 Jul 2025US 12,365,895 B2Genzyme Corporation
- Adeno-associated virus vectors for treatment of Rett syndrome1 Oct 2024US 12,104,163 B2Sarepta Therapeutics, Inc.
- Recombinant adeno-associated viral vectors9 Jan 2024US 11,866,462 B2Oregon Health & Science University
- Agents and methods for treating complement diseases30 Jul 2026US 2026/0217791 A1Complement Therapeutics Limited
- Gene therapy for bves-related disorders6 Nov 2025US 2025/0340902 A1Ohio State Innovation Foundation
- Aav transfer plasmids27 Mar 2025US 2025/0099617 A1Atsena Therapeutics, Inc.
- Constructs comprising neuronal viability factors and uses thereof20 Feb 2025US 2025/0059563 A1Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Adeno-associated virus vectors for treatment of rett syndrome28 Nov 2024US 2024/0392316 A1Sarepta Therapeutics, Inc.
Most cited
By later US patents
- Genetic constructs for delaying or repressing the expression of a target gene369US 6,573,099 B2Benitec Australia Limited · 2003
- Method of inducing an immune response with a live Venezuelan Equine Encephalitis virus expressing a heterologous immunogen123US 5,643,576 AThe University of North Carolina at Chapel Hill · 1997
- Rapid immunoselection cloning method121US 5,506,126 AThe General Hospital Corporation · 1996
- DNA fragment and expression plasmid containing the DNA fragment115US 5,266,491 AMochida Pharmaceutical Co., Ltd. · 1993
- Attenuating mutations in Venezuelan Equine Encephalitis virus63US 5,505,947 AThe University of North Carolina at Chapel Hill · 1996